Dados B3 › EPAR3 × SCAR3
EPAR3 × SCAR3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | EPAR3 | SCAR3 | year |
|---|---|---|---|
| ROE | 0.0% | 4.9% | 2025 |
| ROIC | -5.0%! | 2.6%! | 2025 |
| ROA | -4.6% | -1.6% | 2025 |
| Gross margin | 98.7% | 48.8% | 2025 |
| EBIT margin | -135.7%! | 26.2% | 2025 |
| Net margin | -119.8% | -16.2% | 2025 |
| Net debt/EBITDA | -0.12x | 1.96x | 2023 |
| Current ratio | 2.83x | 1.78x | 2025 |
| Revenue growth (1y) | -90.2% | -41.1% | 2025 |
| Revenue growth (5y CAGR) | -65.0% | -2.6% | 2025 |
| Piotroski F-Score | 3/9 | 3/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | EPAR3 | SCAR3 | year |
|---|---|---|---|
| P/E | — | 12.57x | 2025 |
| P/B | 1.23x | 0.76x | 2025 |
| EV/EBITDA | — | 9.39x | 2025 |
| FCF yield | — | -21.2% | 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 08:20 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 08:20 UTC. If this does not match /saude, you are reading a cached copy.